Novavax (NVAX) shares are falling after JPMorgan downgraded the stock from Neutral to Underweight. Since May, shares surged 250% after the company announced a strategic partnership with Sanofi (SNY).
Market Domination hosts Josh Lipton and Julie Hyman discuss the factors behind the call.
For more expert insight and the latest market action, click here to watch this full episode of Market Domination.
This article was written by Gabriel Roy
Source Agencies
